Netarsudil
id:
netarsudil-318-8271668
title:
Netarsudil
text:
Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension. The European Medicines Agency approved it in 2019 for the same uses under the brand name Rhokiinsa. The FDA considers it to be a first-in-class medication.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Netarsudil
date created:
date modified:
2023-08-31T17:07:27Z
main entity:
{"identifier":"Q27292390","url":"https://www.wikidata.org/entity/Q27292390"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b3/Netarsudil.svg","width":512,"height":186}
fields total:
13
integrity:
15